
Austin Murata
Examiner (ID: 10706, Phone: (571)270-5596 , Office: P/1712 )
| Most Active Art Unit | 1712 |
| Art Unit(s) | 1792, 1712 |
| Total Applications | 876 |
| Issued Applications | 484 |
| Pending Applications | 86 |
| Abandoned Applications | 318 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7286730
[patent_doc_number] => 20040146896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Methods and compositions for diagnosing and treating companion animal cancer'
[patent_app_type] => new
[patent_app_number] => 10/696935
[patent_app_country] => US
[patent_app_date] => 2003-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 42892
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20040146896.pdf
[firstpage_image] =>[orig_patent_app_number] => 10696935
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/696935 | Methods and compositions for diagnosing and treating companion animal cancer | Oct 29, 2003 | Abandoned |
Array
(
[id] => 7434431
[patent_doc_number] => 20040162413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Methods of optimizing antibody variable region binding affinity'
[patent_app_type] => new
[patent_app_number] => 10/697399
[patent_app_country] => US
[patent_app_date] => 2003-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 27656
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 310
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20040162413.pdf
[firstpage_image] =>[orig_patent_app_number] => 10697399
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/697399 | Methods of optimizing antibody variable region binding affinity | Oct 29, 2003 | Abandoned |
Array
(
[id] => 7471455
[patent_doc_number] => 20040096956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Method for generating libraries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules'
[patent_app_type] => new
[patent_app_number] => 10/690396
[patent_app_country] => US
[patent_app_date] => 2003-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9734
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20040096956.pdf
[firstpage_image] =>[orig_patent_app_number] => 10690396
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/690396 | Method for generating libraries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules | Oct 19, 2003 | Abandoned |
Array
(
[id] => 5655203
[patent_doc_number] => 20060140938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Monoclonal antibody specific for ppar gamma, hybridoma cell line producing the same, and method for detecting regulator related to diseases, including inflammation, cancer and metabolic diseases, using the same'
[patent_app_type] => utility
[patent_app_number] => 10/543452
[patent_app_country] => US
[patent_app_date] => 2003-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7883
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0140/20060140938.pdf
[firstpage_image] =>[orig_patent_app_number] => 10543452
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/543452 | Monoclonal antibody specific for PPAR gamma, hydridoma cell line producing the same, and method for detecting regulator related to diseases, including inflammation, cancer and metabolic diseases, using the same | Oct 15, 2003 | Issued |
Array
(
[id] => 5866013
[patent_doc_number] => 20060100144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Conjugates of insulin-like growth factor binding protein-4 and poly (ethylene glycol)'
[patent_app_type] => utility
[patent_app_number] => 10/529090
[patent_app_country] => US
[patent_app_date] => 2003-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11047
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20060100144.pdf
[firstpage_image] =>[orig_patent_app_number] => 10529090
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/529090 | Conjugates of insulin-like growth factor binding protein-4 and poly (ethylene glycol) | Sep 25, 2003 | Abandoned |
Array
(
[id] => 7375082
[patent_doc_number] => 20040219633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Method of producing recombinant antibodies'
[patent_app_type] => new
[patent_app_number] => 10/635908
[patent_app_country] => US
[patent_app_date] => 2003-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5481
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20040219633.pdf
[firstpage_image] =>[orig_patent_app_number] => 10635908
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/635908 | Method of producing recombinant antibodies | Aug 6, 2003 | Abandoned |
Array
(
[id] => 6912255
[patent_doc_number] => 20050176013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Pappss as modifiers of the axin pathway and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/523629
[patent_app_country] => US
[patent_app_date] => 2003-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16066
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176013.pdf
[firstpage_image] =>[orig_patent_app_number] => 10523629
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/523629 | Pappss as modifiers of the axin pathway and methods of use | Aug 5, 2003 | Abandoned |
Array
(
[id] => 5912341
[patent_doc_number] => 20060127403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Use of antibodies against tumor-associated antigen'
[patent_app_type] => utility
[patent_app_number] => 10/524520
[patent_app_country] => US
[patent_app_date] => 2003-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7372
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20060127403.pdf
[firstpage_image] =>[orig_patent_app_number] => 10524520
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/524520 | Use of antibodies against tumor-associated antigen | Jul 30, 2003 | Abandoned |
Array
(
[id] => 6913172
[patent_doc_number] => 20050176930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Marker molecules associated with lung tumors'
[patent_app_type] => utility
[patent_app_number] => 10/515477
[patent_app_country] => US
[patent_app_date] => 2003-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 18747
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10515477
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/515477 | Marker molecules associated with lung tumors | May 15, 2003 | Issued |
Array
(
[id] => 5738088
[patent_doc_number] => 20060008478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Immunoadjuvant'
[patent_app_type] => utility
[patent_app_number] => 10/510708
[patent_app_country] => US
[patent_app_date] => 2003-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4302
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20060008478.pdf
[firstpage_image] =>[orig_patent_app_number] => 10510708
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/510708 | Immunoadjuvant | Apr 14, 2003 | Abandoned |
Array
(
[id] => 7216827
[patent_doc_number] => 20050260208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Binding agents and their use in targeting tumor cells'
[patent_app_type] => utility
[patent_app_number] => 10/510361
[patent_app_country] => US
[patent_app_date] => 2003-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18159
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20050260208.pdf
[firstpage_image] =>[orig_patent_app_number] => 10510361
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/510361 | Binding agents and their use in targeting tumor cells | Apr 10, 2003 | Abandoned |
Array
(
[id] => 7010231
[patent_doc_number] => 20050063947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Method for treating cancer in humans'
[patent_app_type] => utility
[patent_app_number] => 10/508978
[patent_app_country] => US
[patent_app_date] => 2003-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14516
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20050063947.pdf
[firstpage_image] =>[orig_patent_app_number] => 10508978
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/508978 | Method for treating cancer in humans | Mar 26, 2003 | Abandoned |
Array
(
[id] => 113110
[patent_doc_number] => 07714113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-11
[patent_title] => 'Fusion proteins of humanized g250 specific antibodies and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/504389
[patent_app_country] => US
[patent_app_date] => 2003-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 8439
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/714/07714113.pdf
[firstpage_image] =>[orig_patent_app_number] => 10504389
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/504389 | Fusion proteins of humanized g250 specific antibodies and uses thereof | Feb 11, 2003 | Issued |
Array
(
[id] => 386545
[patent_doc_number] => 07303914
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-04
[patent_title] => 'Monoclonal antibody against human hepatoma and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/544036
[patent_app_country] => US
[patent_app_date] => 2003-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 4410
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/303/07303914.pdf
[firstpage_image] =>[orig_patent_app_number] => 10544036
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/544036 | Monoclonal antibody against human hepatoma and use thereof | Jan 29, 2003 | Issued |
Array
(
[id] => 7429023
[patent_doc_number] => 20040001790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Methods for diagnosis and treatment of tumours'
[patent_app_type] => new
[patent_app_number] => 10/336041
[patent_app_country] => US
[patent_app_date] => 2003-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8363
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0001/20040001790.pdf
[firstpage_image] =>[orig_patent_app_number] => 10336041
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/336041 | Methods for diagnosis and treatment of tumours | Jan 2, 2003 | Abandoned |
Array
(
[id] => 6971648
[patent_doc_number] => 20050037358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Method for cloning of variable domain sequences'
[patent_app_type] => utility
[patent_app_number] => 10/499500
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8843
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20050037358.pdf
[firstpage_image] =>[orig_patent_app_number] => 10499500
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/499500 | Method for cloning of variable domain sequences | Dec 19, 2002 | Abandoned |
Array
(
[id] => 7177660
[patent_doc_number] => 20050123896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Screening system for modulators of her2 mediated transcription and her2 modulators identified thereby'
[patent_app_type] => utility
[patent_app_number] => 10/493141
[patent_app_country] => US
[patent_app_date] => 2002-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 27063
[patent_no_of_claims] => 127
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123896.pdf
[firstpage_image] =>[orig_patent_app_number] => 10493141
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/493141 | Screening system for modulators of her2 mediated transcription and her2 modulators identified thereby | Oct 24, 2002 | Abandoned |
Array
(
[id] => 5842248
[patent_doc_number] => 20060121041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Gpcs as modifiers of the irrtk p21 pathways and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/483789
[patent_app_country] => US
[patent_app_date] => 2002-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14453
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20060121041.pdf
[firstpage_image] =>[orig_patent_app_number] => 10483789
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/483789 | Gpcs as modifiers of the irrtk p21 pathways and methods of use | Jul 9, 2002 | Abandoned |
Array
(
[id] => 4644584
[patent_doc_number] => 08022190
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-20
[patent_title] => 'Immuno-molecules containing viral proteins, compositions thereof and methods of using'
[patent_app_type] => utility
[patent_app_number] => 10/482532
[patent_app_country] => US
[patent_app_date] => 2002-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 27
[patent_no_of_words] => 21041
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/022/08022190.pdf
[firstpage_image] =>[orig_patent_app_number] => 10482532
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/482532 | Immuno-molecules containing viral proteins, compositions thereof and methods of using | Jun 17, 2002 | Issued |
Array
(
[id] => 6158893
[patent_doc_number] => 20020147173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Methods of treatment using NBS-1, antibodies and proteins thereto, and uses of the antibodies'
[patent_app_type] => new
[patent_app_number] => 10/155059
[patent_app_country] => US
[patent_app_date] => 2002-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 12411
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20020147173.pdf
[firstpage_image] =>[orig_patent_app_number] => 10155059
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/155059 | Methods of treatment using NBS-1, antibodies and proteins thereto, and uses of the antibodies | May 23, 2002 | Issued |